πŸ‡ΊπŸ‡Έ FDA
Patent

US 11547718

Modulators of FOXP3 expression

granted A61KA61K31/711A61K31/7125

Quick answer

US patent 11547718 (Modulators of FOXP3 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/711, A61K31/7125, A61P, A61P35/00